828
Articles
18.9K
Citations
2.3
avg. Impact Factor
68
h-index

Most Cited Articles of Department of Urology

TitleJournalYearCitations
Epidemiology and risk factors of urothelial bladder cancerEuropean Urology20131.2K
The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysisEuropean Urology2008561
Adverse effects of androgen deprivation therapy and strategies to mitigate themEuropean Urology2015394
Randomized, double-blind placebo- and tolterodine-controlled trial of the once-daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladderBJU International2004314
Updated systematic review and meta-analysis of the comparative data on colposuspensions, pubovaginal slings, and midurethral tapes in the surgical treatment of female stress urinary incontinenceEuropean Urology2010257
A comparison of the efficacy and tolerability of solifenacin succinate and extended release tolterodine at treating overactive bladder syndrome: results of the STAR trialEuropean Urology2005257
Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinomaJournal of Clinical Oncology2005249
EAU guidelines on urinary incontinenceEuropean Urology2011245
Muscarinic receptor antagonists in the treatment of overactive bladderUrology2000236
Detrusor underactivity and the underactive bladder: a new clinical entity? A review of current terminology, definitions, epidemiology, aetiology, and diagnosisEuropean Urology2014234
The ICS-'BPH' Study: the psychometric validity and reliability of the ICSmale questionnaireBritish Journal of Urology1996223
Urothelium-derived inhibitory factor(s) influences on detrusor muscle contractility in vitroBritish Journal of Pharmacology2000218
Development of a UV crosslinked biodegradable hydrogel containing adipose derived stem cells to promote vascularization for skin wounds and tissue engineeringBiomaterials2017217
Silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: results of an international, randomized, double-blind, placebo- and active-controlled clinical trial performed in EuropeEuropean Urology2011194
The effects of antimuscarinic treatments in overactive bladder: a systematic review and meta-analysisEuropean Urology2005182
Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trialLancet Oncology, The2017176
Mirabegron in overactive bladder: a review of efficacy, safety, and tolerabilityNeurourology and Urodynamics2014176
The role of urinary urgency and its measurement in the overactive bladder symptom syndrome: current concepts and future prospectsBJU International2005176
A contemporary assessment of nocturia: definition, epidemiology, pathophysiology, and management--a systematic review and meta-analysisEuropean Urology2012173
Tissue-engineered buccal mucosa urethroplasty-clinical outcomesEuropean Urology2008165
Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT studyBMJ, The2012163
Buccal mucosal urethroplasty: is it the new gold standard?BJU International2004160
Consensus statement on urethral traumaBJU International2004143
Generalised increase in bone resorption in carcinoma of the prostateBritish Journal of Urology1985132
Behavior of urothelial carcinoma with respect to anatomical locationJournal of Urology2007131